Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-18-000006
Filing Date
2018-01-19
Accepted
2018-01-19 10:15:17
Documents
1
Period of Report
2018-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151637490293134.html 4  
1 FORM 4 wf-form4_151637490293134.xml 4 3846
  Complete submission text file 0001615219-18-000006.txt   5236
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FLEX PHARMA, INC. 800 BOYLSTON STREET, 24TH FLOOR BOSTON MA 02199
Business Address
Woo Elizabeth (Reporting) CIK: 0001630686 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 18535694